Viridian Therapeutics Ors Inc (VRDN)
Cost of Revenue
$320.00K
TTM · Period ending: · USD
VRDN Cost of Revenue
Latest reported$320.00Kperiod ending
Latest reported$320.00Kperiod ending
VRDN TTM Cost of Revenue ($2.37M → $320.00K)
TTM cost of revenue
High-resolution chart · PNG
VRDN cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 320,000 | |
| 320,000 | |
| 320,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 39,317,000 | |
| 61,436,000 | |
| 83,148,000 | |
| 100,894,000 | |
| 83,971,000 | |
| 69,973,000 | |
| 60,826,000 | |
| 56,886,000 | |
| 49,746,000 | |
| 41,625,000 | |
| 29,060,000 | |
| 15,254,000 | |
| 6,417,000 | |
| 15,444,000 | |
| 24,043,000 | |
| 32,794,000 | |
| 34,611,000 | |
| 32,983,000 | |
| 32,759,000 | |
| 30,421,000 | |
| 27,185,000 | |
| 24,804,000 | |
| 21,916,000 | |
| 19,623,000 | |
| 15,317,000 | |
| 10,898,000 | |
| 6,039,000 | |
| 2,548,000 | |
| 2,312,000 | |
| 2,290,000 | |
| 2,340,000 | |
| 2,471,000 | |
| 2,924,784 | |
| 3,219,306 | |
| 3,217,037 | |
| 3,120,551 | |
| 2,599,384 | |
| 2,441,062 | |
| 2,368,385 | |
| 2,373,838 |